Sr. Associate (Acquisitions)

Overview

Entrepreneurial Spirit, Rooted in Tradition. Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a U.S. subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC) in Japan, which touts a storied reputation more than three hundred years in the making. Our parent company - one of Japan’s most respected - is a research-driven pharmaceutical company that has tirelessly pursued medical breakthroughs with global reach. MTPC has discovered and produced several first-in-class medicines for serious diseases, including multiple sclerosis (MS), diabetes mellitus (DM), amyotrophic lateral sclerosis (ALS), and is currently developing medicines in Neurology, Parkinson’s (PD), Spinal Cord Injury (SCI), and high unmet areas in Immunology and Oncology.

 

MTPA is rapidly expanding its operations across all functional areas. MTPA’s commitment to patients and their communities continues with a robust late-stage pipeline of investigational treatments for difficult-to-treat diseases and commercializing products with significant unmet medical needs in North American markets.  In the United States, MTPA launched rare disease treatments including RADICAVA® (edaravone) IV infusion in 2017 and RADICAVA® (edaravone) oral suspension in 2022.  The company handles research, clinical development, sales, marketing, medical affairs, supply chain, and business development functions.  MTPA is dedicated to improving the treatment environment for those with debilitating diseases, researching on real-world evidence, and creating hope for all facing illness.   

 

MP Healthcare Venture Management (MPH), a Boston-based affiliate of MTPA, is the venture capital arm of MTPC, and it plays a key role in supporting biotech innovation. MPH has established itself as a trusted partner for innovative biotech companies in the U.S. and globally, contributing to the success of numerous startups.

 

Together, MTPA and MPH embody a commitment to advancing healthcare and delivering meaningful solutions to patients in North America and around the world.

 

The Senior Associate will be a key member of the MPH team, taking on a variety of responsibilities to support investment in new opportunities, management of portfolio companies, and governance of MPH.

Responsibilities

• Supports the company’s investment in new opportunities:
  • Proactively sources new investment opportunities, carries out initial review, and presents top opportunities to the larger MPH team
  • Takes a key role in evaluating new strategic areas (i.e. technology platforms, new disease areas), and identifying leading companies in those areas through various research techniques
  • Carries out due diligence of top priority companies, coordinating review by technical experts and IP consultants
  • Participate sin reviewing and negotiating financing deal terms and identifying other venture capital (VC) firms for co-investment
• Participates in the management of portfolio companies:
  • Serves as Board Member (or Observer) for one or more companies in which MPH invests
  • Provides strategic, business development (BD) and technical guidance to portfolio management
• Supports governance of MPH:
  • Takes an active role in supporting the management of MPH, including setting strategy, investment goals and budget
  • Participates in dialogue with parent company MTPC as well as US-based subsidiaries to help achieve MTPC’s overall strategic goals
• Performs other duties as required.

Qualifications

• Advanced degree in life sciences (MD, PhD, PharmD).
• In addition to above, an MBA is preferred.
• At least 3 years of solid business experience, preferably in the biotech/pharma industries (direct employee or consultant).
• Strong technical/scientific orientation; ability to quickly grasp new scientific concepts.
• Sound business analysis, business judgement and decision-making skills.
• A working knowledge of the venture capital investment process is preferred.
• Excellent research skills.
• Excellent interpersonal, oral/written communications and networking skills; able to form strong relationships at the highest levels, both internally and externally.
• Proven ability to manage confidential information with great discretion.
• Ability to work well in a small team, exhibiting a healthy balance between independent drive and commitment to maintaining a collaborative environment.
• Willingness to travel up to 30% both domestically and internationally.

 

Our Value Proposition:

Enjoy the fast-moving, entrepreneurial spirit more typically found in a small biotech, complemented by the benefits of a global pharmaceutical/chemical conglomerate. At this time, Mitsubishi Tanabe Pharma Am